SAN DIEGO, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the ...
*Baseline is referred to as start of HOPE-2 OLE study, changes in means are shown “I am extremely encouraged by these positive results from our HOPE-2 OLE study which continue to support the long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback